Cell-free DNA as a biomarker after lung transplantation: A proof-of-concept study.
Jesper M MagnussonAnne RickstenGöran DellgrenCarina WasslavikRickard NordénJohan WestinJens BoehmerPublished in: Immunity, inflammation and disease (2022)
This proof-of-concept study suggests that cfDNA quantified with PCR may be used as a biomarker of significant clinical events such as CLAD.
Keyphrases